A targeted antisense therapeutic approach for Hutchinson–Gilford progeria syndrome - Nature Medicine

A modified antisense oligonucleotide that blocks pathogenic splicing of progeria transcripts reduces the production of progerin in key target organs and extends animal lifespan in mouse model of progeria syndrome.